THE Generics and Biosimilar Medicines Association (GBMA) has confirmed the appointment of Marnie Peterson as its new Chief Executive Officer.
Peterson (pictured) is currently based in Melbourne as head of commercial for Dr Reddy's Laboratories, with a range of previous pharmaceutical industry roles in marketing with Actavis/Allergen and Apotex.
She takes the place of Belinda Wood, who resigned as GBMA ceo last year after about five years in the role (PD 20 Oct 2017).
GBMA chair Allan Tillack said he was delighted to welcome Peterson, hailing her "vast experience and a strong record of accomplishment in the generics sector and actioning strategic objectives.
Tillack said the association has a full agenda for 2018, with the GBMA working to deliver the outcomes identified as part of its strategic agreement extension negotiated in the 2017 Federal Budget.
"Marnie is well placed to progress this exciting agenda and we are looking forward to her joining us towards the end of March," he said.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Feb 18
